In this episode of The Diabetes Wellness
Forum, titled “Importance of Early Aggressive Glucose Control-Approach in
2025,” Dr Nandita Mohan from Medical Dialogues is in conversation with Dr
Vaishali Deshmukh, Consultant Diabetologist & Endocrinologist at Deenanath
Mangeshkar Hospital, Pune, Maharashtra and Dr Altamash Shaikh, Consultant
Endocrinologist & Diabetologist and Metabolic Physician, Saifee Hospital,
Mumbai, Maharashtra, to discuss a critical aspect of diabetes care in 2025.
With Type 2 diabetes increasingly affecting
younger individuals in India and showing rapid disease progression, early and
effective glucose control has become essential to prevent long-term
microvascular and macrovascular complications. It highlights real-world
strategies and contemporary approaches to early aggressive glucose management
in 2025.
During this episode, the experts address
three key clinical questions:
1. What is the burden of uncontrolled Type
2 diabetes and the major clinical challenges in managing these patients?
2. What is the clinical utility of the
empagliflozin, sitagliptin, and metformin combination in uncontrolled Type 2
diabetes?
3. Which patient profiles are best suited
for empagliflozin, sitagliptin, and metformin fixed-dose combination therapy?